WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013049278) USE OF IL-1 ß BINDING ANTIBODIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/049278    International Application No.:    PCT/US2012/057444
Publication Date: 04.04.2013 International Filing Date: 27.09.2012
IPC:
A61K 39/395 (2006.01), C07K 16/24 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35 CH-4056 Basel (CH) (For All Designated States Except US).
THUREN, Tom [US/US]; (US) (US only).
ZALEWSKI, Andrew [US/US]; (US) (US only).
SHETZLINE, Michael [US/US]; (US) (US only)
Inventors: THUREN, Tom; (US).
ZALEWSKI, Andrew; (US).
SHETZLINE, Michael; (US)
Agent: FISCHER, Leslie; Novartis Pharmaceuticals Corporation Patent Department, Bldg. 101 One Health Plaza East Hanover, New Jersey 07936-1080 (US)
Priority Data:
61/541,341 30.09.2011 US
Title (EN) USE OF IL-1 ß BINDING ANTIBODIES
(FR) UTILISATION D'ANTICORPS DE LIAISON IL-1 SS
Abstract: front page image
(EN)The present invention relates to an IL-1β binding antibody or a functional fragment thereof for use in preventing or reducing risk of experiencing a recurrent cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered of a qualifying CV event.
(FR)L'invention porte sur un anticorps de liaison IL-1 ß ou sur un fragment fonctionnel de ce dernier, qui sont utilisés pour prévenir ou réduire le risque d'événement cardiovasculaire ou de récidive d'événement cardiovasculaire chez un patient ayant déjà souffert d'un événement cardiovasculaire qualifié.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)